| Literature DB >> 33395273 |
Min Liu1, Yang-Chen Lin1, Jiao-Jiao Guo1, Meng-Meng Du1, Xinyi Tao1, Bei Gao1, Ming Zhao1, Yushu Ma1, Feng-Qing Wang1, Dong-Zhi Wei1.
Abstract
Patchoulol is a tricyclic sesquiterpene widely used in perfumes and cosmetics. Herein, comprehensive engineering strategies were employed to construct an efficient yeast strain for patchoulol production. First, a platform strain was constructed via pathway modification. Second, three off-pathway genes were deleted, which led to significant physiological changes in yeast. Further, strengthening of the ergosterol pathway, enhancement of the energy supply, and a decrease in intracellular reactive oxygen species were implemented to improve the physiological status of yeast, demonstrating a new promotive relationship between ergosterol biosynthesis and synthesis of patchoulol. Moreover, patchoulol synthase was improved through protein modification and Mg2+ addition, reaching a final titer of 141.5 mg/L in a shake flask. Finally, a two-stage fermentation with dodecane addition was employed to achieve the highest production (1632.0 mg/L, 87.0 mg/g dry cell weight, 233.1 mg/L/d) ever reported for patchoulol in a 5 L bioreactor. This work lays a foundation for green and efficient patchoulol production.Entities:
Keywords: Saccharomyces cerevisiae; cell factories; metabolic engineering; patchoulol; physiological status; sesquiterpene
Year: 2021 PMID: 33395273 DOI: 10.1021/acssynbio.0c00521
Source DB: PubMed Journal: ACS Synth Biol ISSN: 2161-5063 Impact factor: 5.110